Assort Health
Assort Health develops generative AI voice agents for healthcare call centers, automating patient scheduling, prescription refills, and intake workflows.
Secondary Market Price
Secondary Market Price
How Assort Health Measures Up
To help you manage your Assort Health equity, Prospect has run the company through our machine learning model.
Prospect Rating
TBD
We are still evaluating the data for Assort Health to determine our rating. Check back soon for our forecast on the company's potential value in four years.
Exit Risk
TBD
We are still gathering data on Assort Health to train our machine learning model. Check back soon for our exit risk rating for Assort Health!
Funding Stage
Series B+
A Series B+ funding round means Assort Health is on solid ground, having moved beyond the early, riskiest stages of a startup. This translates to a role with more stability than an early-stage company, but still offers the significant growth and impact opportunities of a business that's rapidly scaling.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Assort Health's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Assort Health Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Assort Health's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Assort Health develops and deploys generative AI agents for healthcare call centers. The company’s voice AI system is designed to answer patient calls and handle tasks such as appointment management, prescription refills, triage, and intake workflows, integrating with existing electronic health records and customer management systems. Founded in 2023 and headquartered in San Francisco, CA, the company has supported over 55 million patient interactions and expanded its team significantly. According to its funding history, Assort Health has completed four funding rounds, with a Series B round closing on September 26, 2025, which raised $76.0 million.
Looking forward, Assort Health is continuing to scale its teams, with recent announcements detailing the hiring of a workplace manager and senior technical recruiters. The company maintains a presence at industry conferences, with co-CEO Jon Wang speaking at Becker's Healthcare events and planned participation in the Digestive Health Physicians Association (DHPA) Conference in November 2025. The company also hosts roundtable events for industry leaders to discuss patient access goals and recently held a company offsite to mark growth and milestones.
- Lightspeed
- Felicis
- First Round
- Liquid2
- Quiet Capital
- Co-Founder, CEO Jeff (Jeffery) Liu
- Co-Founder, Co-CEO Jon Wang
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Assort Health worth joining?
Deciding whether to join any startup depends on your personal career goals, risk tolerance, and financial situation. Tools like Prospect can help you model the potential value of an equity offer to make a more informed financial decision.
What should I do with my Assort Health stock?
The best course of action for your private company stock involves complex tax and financial planning unique to your circumstances. Platforms such as Prospect offer personalized strategies for exercising options and selling shares to help maximize your post-tax returns.
Can you sell Assort Health stock?
As Assort Health is a private company, selling stock is typically possible only during specific liquidity events like tender offers or approved secondary sales. You can use tools from services like Prospect to help decide how much to sell and identify which shares are most tax-optimal during these opportunities.
How can I find the value of my Assort Health stock?
The value of private stock is formally determined by a 409A valuation, but this may not reflect its potential future worth. To better understand its potential, you can use platforms like Prospect, which leverage predictive models to forecast your equity's future value.
What is Assort Health's equity worth?
The precise worth of private equity is not public information and changes based on the company's performance, market conditions, and latest valuation. Services such as Prospect can help you model different financial scenarios and project the potential future value of your holdings.
What is Assort Health's stock ticker symbol?
Because Assort Health is a private company, it does not have a stock ticker symbol. Ticker symbols are assigned only when a company becomes publicly traded on a stock exchange.
Can I buy or sell Assort Health stock?
As an employee, you can typically "buy" stock by exercising your vested options, while opportunities to sell are usually limited to specific company-approved windows. Equity management platforms like Prospect provide tools and tax-optimized strategies for both exercising options and selling shares.
What is the criteria to buy or invest in Assort Health stock?
Investing in a private company like Assort Health is generally restricted to employees receiving equity compensation or accredited investors in private funding rounds. For employees who already hold equity, platforms like Prospect focus on helping you manage and maximize its value, rather than providing external investment criteria.
